<DOC>
	<DOCNO>NCT01413698</DOCNO>
	<brief_summary>People respiratory infection , asthmatic patient cystic fibrosis ( CF ) patient suffer multitude pathology airway often inflict chronic cough . Treatment cough patient consist many type expectorant , cough suppressor , secretion modifier , inhale bronchodilator etc . In addition , chest physical therapy ( PT ) often prescribed part treatment regime . The assessment cough currently subjective base symptom qualitative description express patient parent . Quantitative objective method cough assessment available beyond investigative laboratory unique specific investigator .</brief_summary>
	<brief_title>Cough Count Validation</brief_title>
	<detailed_description>Cough part defense mechanism protect lung foreign particle remove secretion airway . While cough reflex essential protect lung foreign material infection , excessive chronic presence bothersome might interfere quality life , sleep pattern exercise tolerance patient . Such symptom may potentially indicative on-going pathological process , . People respiratory infection , asthmatic patient CF patient suffer multitude pathology airway often inflict chronic cough . Treatment cough patient consist many type expectorant , cough suppressor , secretion modifier , inhale bronchodilator etc . In addition , chest physical therapy ( PT ) often prescribed part treatment regime . The assessment cough currently subjective base symptom qualitative description express patient parent . Quantitative objective method cough assessment available beyond investigative laboratory unique specific investigator . The primary objective study evaluate efficacy validity novel cough counting device base WIM Technology . The PulmoTrack™ technology include PulmoTrack™ 3010/5050 device intend analysis , interpretation record lung sound , Automatic Cough Counting Application . The recording lung sound performed PulmoTrack™ 3010/5050 device . The lung sound subsequently analyze presence wheeze presence cough Automatic Cough Counting Application ( ACCA ) . The technology enable accurate cough count time well wheeze detection time .</detailed_description>
	<mesh_term>Cough</mesh_term>
	<criteria>Age 280 year . Patients significant chronic cough . Patients hemodynamic stability . Patient respiratory distress . Subject subject 's parents/guardians able comprehend give informed consent participation study . Contraindication use PulmoTrack™ performing ARM ( Acoustic Respiratory Monitoring ) . Hemodynamic instability and/or SOB . Concurrent additional major illness . Concurrent participation study . Physician objection</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>